6. Parkinson disease Clinical trials / Disease details

Clinical trials : 2,298 / Drugs : 2,202 - (DrugBank : 350) / Drug target genes : 188 - Drug target pathways : 202

6 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04687878 (ClinicalTrials.gov)	January 1, 2020	28/12/2020	The Effect of Intranasal Insulin on Motor and Non-motor Symptoms in Parkinson's Disease Patients	Evaluating the Effect of Intranasal Insulin Administration on Motor and Non-motor Symptoms in Parkinson's Disease Patients; a Randomized Double-blinded Placebo-controlled Clinical Trial	Parkinson Disease	Drug: Insulin;Drug: Normal saline	dr.dargahi	NULL	Recruiting	17 Years	N/A	All	40	Phase 2	Iran, Islamic Republic of
2	ChiCTR2000037957	2016-12-01	2020-09-07	Clinical study of dexmedetomidine on deep brain stimulation in middle-aged and elderly patients with Parkinson's disease	Clinical study of dexmedetomidine on deep brain stimulation in middle-aged and elderly patients with Parkinson's disease	Deep brain stimulation in patients with Parkinson's disease	Experimental group:conscious sedation with dexmedetomidine;control group:Pump in normal saline;	Shanghai Jing'an District Central Hospital	NULL	Completed	45	75	Both	Experimental group:27;control group:9;		China
3	NCT02018406 (ClinicalTrials.gov)	December 2013	30/10/2013	Establishment of Clinical Basis for Hematopoietic Growth Factors Therapy in Brain Injury		Neurological Diseases;Ischemic Stroke;Hemorrhagic Stroke;Cerebral Palsy;Atypical Parkinson Disease	Drug: Combination injection of EPO and G-CSF;Drug: Injection of normal saline	Yonsei University	NULL	Active, not recruiting	20 Years	N/A	All	16	Phase 1/Phase 2	Korea, Republic of
4	NCT01313819 (ClinicalTrials.gov)	April 2011	10/3/2011	The Effect of IV Amantadine on Freezing of Gait (FOG) Resistant to Dopaminergic Therapy	A Double Blind, Placebo-controlled Study for the Effect of IV Amantadine on Freezing of Gait (FOG) Resistant to Dopaminergic Therapy	Parkinson`s Disease;Freezing of Gait	Drug: PK-Merz ® 200mg/500ml inj(Amantadine) , Normal saline 500ml inj	Seoul National University Hospital	NULL	Recruiting	30 Years	80 Years	Both	20	Phase 4	Korea, Republic of
5	NCT00608231 (ClinicalTrials.gov)	January 2008	7/1/2008	Dexmedetomidine Effects on Microelectrode Recording in Deep Brain Stimulation	Dexmedetomidine Effects on Microelectrode Recording in Deep Brain Stimulation	Parkinson's Disease;Essential Tremor;Dystonia	Drug: Dexmedetomidine Hydrochloride Infusion;Drug: Normal Saline	Vanderbilt University	NULL	Withdrawn	18 Years	N/A	Both	0	Phase 2/Phase 3	United States
6	NCT00623363 (ClinicalTrials.gov)	April 2007	2/1/2008	Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease		Parkinson's Disease	Drug: piclozotan;Drug: 0.9% sodium chloride (normal saline)	Asubio Pharmaceuticals, Inc.	NULL	Completed	40 Years	85 Years	Both	27	Phase 2	United States;Guatemala;Romania